EGLN1 and cancer: Similar kinds of manifestations were also noted in toxic control after MNU administration, i.e., the increase in HIF-1α, SREBP-1c, FASN but a decrease in PHD-2, which indicated the development of cancer hypoxia in these animals (Fig. 8).